Form 4 for HCA HCA Healthcare
Accepted 2024-11-14 00:00:00 ET · period of report 2024-11-12 · accession 0000950170-24-127310 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-14 | 2024-11-12 | HCA | Akdamar Erol R | Group Pres | F - Tax | $350.53 | -10.3K | 9,743 | -51% | -$3.60M |
| D | 2024-11-14 | 2024-11-12 | HCA | Akdamar Erol R | Group Pres | M - OptEx | $68.96 | +20.0K | 20.0K | New | +$1.38M |
| D | 2024-11-14 | 2024-11-14 | HCA | Akdamar Erol R | Group Pres | S - Sale+OE | $353.00 | -2,900 | 6,843 | -30% | -$1.02M |
| D | 2024-11-14 | 2024-11-12 | HCA | Akdamar Erol R | Group Pres | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-12 | F | D | 10,257 | $350.53 | 9,743 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-12 | M | A | 20,000 | $68.96 | 20,000 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-14 | S | D | 2,900 | $353.00 | 6,843 | D | — | — | |
| 4 | Derivative | Stock Appreciation Right | 2024-11-12 | M | D | 20,000 | $0.00 | 0 | D | $68.96 · — to 2025-02-04 | 20,000 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. |